BioBridgeXAll companies

Kano Therapeutics Inc.

Biotechnology company · Cambridge, Massachusetts, United States

Kano Therapeutics Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2021. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $349,952 in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $5 million sold in a notice filed in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

Kano Therapeutics at a glance

Typebiotechnology company
HeadquartersCambridge, Massachusetts, United States
Earliest incorporation on record2021
Employees (self-reported, 2025)6
SEC CIK2023721

What does Kano Therapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $349,952 in total (2025). NIH funding came from the National Institute of General Medical Sciences.

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $5 million sold (2024).

Frequently asked questions about Kano Therapeutics

Where is Kano Therapeutics headquartered?

Kano Therapeutics Inc. is headquartered in Cambridge, Massachusetts, United States.

What does Kano Therapeutics do?

Kano Therapeutics Inc. is a biotechnology company.

When was Kano Therapeutics founded?

The earliest incorporation on record for Kano Therapeutics Inc. is in 2021, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences